Towards Healthcare
Gene Prediction Tools Market
Updated Date: 27 January 2026   |   Report Code: 5775
sales@towardshealthcare.com +1 804-441-9344
Download Sample Order Now

Gene Prediction Tools Market Shaped by AI and NGS Demand Growth

Projections indicate that, the global gene prediction tools market will increase from USD 237.44 million in 2025 to USD 1320.67 million by 2035, experiencing a CAGR of 18.72% over the next 10 years. Currently, the respective market is driven by the accelerating demand for personalized treatments in different conditions and the reduction in expenditure on sequencing technologies. Furthermore, North America dominated the market due to the presence of a robust research infrastructure, funding facilities, which allow the development of personalized medicine in the growing chronic disease cases.

Last Updated : 27 January 2026 Category: Biotechnology Insight Code: 5775 Format: PDF / PPT / Excel

Content

TOC is not Available for this Report

FAQ's

Answer : The gene prediction tools market is valued at USD 281.89 million in 2026 and is projected to reach USD 1320.67 million by 2035, growing at a CAGR of 18.72%.

Answer : While North America dominates 42% share in 2024 due to strong R&D ecosystems and chronic disease prevalenc.

Answer : Key players include Thermo Fisher Scientific, Illumina, Qiagen, Softberry, DNASTAR, Genscript, BGI Genomics, and MedGenome.
Any Questions

Meet the Team

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology and healthcare services.

Learn more about Deepa Pandey

Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.

Learn more about Aditi Shivarkar